bluebird bio, Inc.
NASDAQ:BLUE
4.97 (USD) • At close June 2, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Revenue
| 83.807 | 29.497 | 3.597 | 3.662 | 250.734 |
| Cost of Revenue
| 89.38 | 33.527 | 10.077 | 38.857 | 5.396 |
| Gross Profit
| -5.573 | -4.03 | -6.48 | -35.195 | 245.338 |
| Gross Profit Ratio
| -0.066 | -0.137 | -1.802 | -9.611 | 0.978 |
| Reseach & Development Expenses
| 94.252 | 167.652 | 240.764 | 319.946 | 319.309 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 |
| SG&A
| 167.874 | 165.51 | 136.908 | 209.969 | 239.95 |
| Other Expenses
| 2.762 | -92.93 | -133.967 | 25.801 | 315.593 |
| Operating Expenses
| 264.888 | 240.232 | 243.705 | 555.716 | 874.852 |
| Operating Income
| -270.461 | -244.262 | -250.185 | -590.911 | -559.259 |
| Operating Income Ratio
| -3.227 | -8.281 | -69.554 | -161.363 | -2.23 |
| Total Other Income Expenses Net
| 29.816 | 32.223 | 19.96 | 28.531 | -1.111 |
| Income Before Tax
| -240.645 | -212.039 | -230.225 | -562.38 | -560.37 |
| Income Before Tax Ratio
| -2.871 | -7.188 | -64.005 | -153.572 | -2.235 |
| Income Tax Expense
| 0.07 | -0.126 | 0.117 | 0.258 | 0.686 |
| Net Income
| -240.715 | -211.913 | -230.342 | -819.378 | -618.695 |
| Net Income Ratio
| -2.872 | -7.184 | -64.037 | -223.752 | -2.468 |
| EPS
| -24.84 | -2.97 | -3.39 | -8.16 | -9.95 |
| EPS Diluted
| -24.84 | -2.97 | -3.39 | -8.16 | -9.95 |
| EBITDA
| -156.822 | -167.161 | -215.559 | -556.926 | -553.633 |
| EBITDA Ratio
| -1.871 | -5.667 | -59.927 | -152.082 | -2.208 |